Article

Skyscape's iPhone App Proves to be Popular

Over 100,000 healthcare professionals have downloaded Skyscape's iPhone application. Have you?

Over 100,000 healthcare professionals have downloaded Skyscape's iPhone application. Have you?

One great aspect about the iPhone is its ability to run applications. Many healthcare app developers have created iPhone-specific versions of their software so it can be used by medical professionals wherever they happen to be. Skyscape is one such company.

Skyscape's software includes a portfolio providing access to drug information, drug interactions, clinical and evidence-based information, and guidelines. It also offers its MedAlert service, which provides medical news, research and clinical trials updates, and journal summaries by specialty.

The software is a hit. Andrew Schuman, MD, a practicing pediatrician, said, "My needs for the clinical information are met with Skyscape's specialty specific portfolio that goes well beyond the drug information offered by others. I can truly rely on Skyscape's trusted decision support resources at the point of care." Schuman is also contributing editor of Contemporary Pediatrics, and Adjunct Assistant Professor of Pediatrics, Dartmouth Medical School, Hanover, NH.

According to Sandeep Shah, Skyscape's president and CEO, downloads of the free software doubled during the fourth quarter, reaching 8,000 downloads per day. Skyscape isn't the only iPhone-specific software out there.

Hundreds of applications are available via the iTunes Apps Store. Do you use your mobile phone for your practice? If so, what software are you using and for what purpose?

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.